Vericel Corporation (VCEL) Live Share Price, Invest From India

Vericel Corporation Stock Performance

as on March 25, 2026 at 6:10 am IST

Day's Low
Day's High
$32.02
Day's Price Range
$33.50
$33.30
3.84%
Downside
0.60%
Upside
52 Week's Low
52 Week's High
$29.24
52-Week Price Range
$48.75
$33.30
12.19%
Downside
46.38%
Upside

Vericel Corporation share price movements today

Previous Close: $32.45
Open: $32.03
Volume: 296.7K
Day's Low - High: $32.02 - $33.50
52 Week Low - High: $29.24 - $48.75

Vericel Corporation Historical Returns

1 Month Return: -17.88 %
3 Month Return: -15.97 %
1 Year Return: -32.1 %
3 Year Return: + 9.02 %
5 Year Return: -43.48 %

Vericel Corporation Stock Fundamentals & Key Indicators

Check Vericel Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.6B

EPS (TTM)

0.41

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.19%

PE Ratio (TTM)

98.16

Industry PE ratio

7.887522123893805

PEG Ratio

EBITDA

22.6M

Revenue (TTM)

276.3M

Profit Margin

5.98%

Return On Equity TTM

5.11%

Vericel Corporation Stock Valuation

Track how Vericel Corporation P/E has moved over time to understand its valuation trends.

Vericel Corporation in the last 5 years

Overview
Trends

Lowest (-150.74x)

September 30, 2023

Industry (7.89x)

March 23, 2026

Today (98.16x)

March 23, 2026

Highest (149.61x)

September 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 98.16x

Vericel Corporation vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vericel Corporation with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Vericel Corporation	BUY	$1.6B	-43.48%	98.16	5.98%
Alnylam Pharmaceuticals, Inc.	BUY	$41.4B	125.13%	133.41	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$115.3B	112.56%	29.67	32.94%
Beone Medicines Ltd	NA	$31.6B	NA	111	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$77.5B	56.01%	17.67	31.41%

Stock Returns calculator for Vericel Corporation Stock including INR - Dollar returns

The Vericel Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Vericel Corporation investment value today

Current value as on today

₹81,525

Returns

₹18,475

(-18.47%)

Returns from Vericel Corporation Stock

₹28,016 (-28.02%)

Dollar Returns*

₹9,541 (+9.54%)

Analyst Recommendation on Vericel Corporation Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Vericel Corporation. Average target price of $55.43

Vericel Corporation Share Price Target

Get share price movements and forecasts by analysts on Vericel Corporation.

What analysts predicted

39.92%UPSIDE

Target Price

$55.43

Current Price

$33.3

Analyzed by

12 Analysts

Target

$55.43

Vericel Corporation target price $55.43, a slight upside of 39.92% compared to current price of $33.3. According to 12 analysts rating.

Vericel Corporation Stock’s Investor Sentiment and Interest

Search interest for Vericel Corporation Stock has decreased by -30% in the last 30 days, reflecting a downward trend in search activity.

Time period: February 23, 2026 to March 25, 2026

Change:-30% versus previous 30 day period

Vericel Corporation Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	45	64	51	52	57	75	52	63	67	92
Gross Profit	30	48	35	36	41	58	36	46	49	73
Operating Income	-5	12	-5	-6	-2	18	-12	-2	3	22
EBITDA	-2	15	-2	-3	0	21	-8	2	8	27
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	1	1	1	1	1	1	2	2	2	3
Income Before Tax	-3	14	-3	-4	0	19	-11	0	5	24
Income Tax Expense	0	1	1	-	-	0	-	-	-	0
Net Income	-3	12	-3	-4	0	19	-11	0	5	23
Net Profit Margin	-8.03%	19.99%	-7.53%	-8.89%	-1.56%	26.28%	-21.38%	-0.87%	7.52%	25.01%

Vericel Corporation Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	54	63	90	117	124	156	164	197	237	276
Gross Profit	26	33	58	80	84	106	109	135	172	205
Operating Income	-19	-14	-3	-11	2	-7	-17	-6	4	11
EBITDA	-17	-14	-4	-7	5	-4	-11	2	16	30
Interest Expense	0	1	1	0	0	0	0	0	0	1
Depreciation	-	1	1	1	2	2	3	4	5	11
Income Before Tax	-19	-17	-8	-9	3	-7	-15	-2	10	17
Income Tax Expense	2	1	3	-1	0	0	0	0	0	0
Net Income	-19	-17	-8	-9	2	-7	-16	-3	10	16
Net Profit Margin	-35.98%	-27.04%	-8.96%	-8.20%	2.31%	-4.78%	-10.17%	-1.61%	4.37%	5.98%

Vericel Corporation Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	12	-3	-4	0	19	-11	0	5	23
Operating Cash Flow	10	7	18	10	22	6	8	22	15
Investing Cash Flow	-8	-25	-17	-21	-14	-15	-9	-3	-16
Financing Cash Flow	1	2	4	5	7	3	1	1	1
Change in Cash	3	-16	5	-5	14	-5	0	19	0

Vericel Corporation Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-17	-8	-9	2	-7	-16	-3	10	16
Operating Cash Flow	-13	0	-7	17	29	17	35	58	51
Investing Cash Flow	-1	-67	10	-17	-3	-36	-3	-79	-43
Financing Cash Flow	18	58	5	6	9	1	3	19	7
Change in Cash	3	-8	8	6	34	-17	35	-1	15

Global Institutional Holdings in Vericel Corporation

Funds	Holdings
Brown Capital Management, LLC	3.86%
Geneva Capital Management	3.61%
Geode Capital Management, LLC	2.41%
Federated Hermes Inc	1.77%
Capital Research Global Investors	1.68%

See all

Insights on Vericel Corporation

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 3 Years
In the last 3 years, VCEL has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, 52.59M → 92.91M (in $), with an average increase of 16.8% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 4 quarters, -11.24M → 23.24M (in $), with an average increase of 707.6% per quarter
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 11.4% return, outperforming this stock by 43.7%
NEGATIVE IMPACT
Price Dip
In the last 1 month, VCEL stock has moved down by -15.2%

About Vericel Corporation

about vericel founded in 1989, vericel (formerly aastrom biosciences), is dedicated to the development of patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. the company markets two cell therapy products in the united states, carticel® (autologous cultured chondrocytes), an autologous chondrocyte implant for the treatment of cartilage defects in the knee and epicel® (cultured epidermal autografts), a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to 30% of total body surface area. vericel is also developing maci, a third-generation autologous chondrocyte implant for the treatment of cartilage defects in the knee, and ixmyelocel-t, a patient specific multicellular therapy for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy (dcm). to fulfill vericel’s mission of helping people with severe diseases and conditions rea

Organisation	Vericel Corporation
Headquarters	64 Sidney Street, Cambridge, MA, United States, 02139
Industry	Health Technology
CEO	Mr. Dominick C. Colangelo Esq.
E-voting on shares	Click here to vote

Key Management of Vericel Corporation

Name	Title
Mr. Mike Gilligan	Senior Vice President of Sales
Mr. Joseph Anthony Mara Jr.	CFO & Treasurer
Mr. Michael Halpin	Chief Operating Officer
Mr. Sean C. Flynn	Chief Legal Officer
Mr. Jonathan D. Siegal	Principal Accounting Officer, VP & Corporate Controller
Mr. Eric Burns	Vice President of Finance & Investor Relations
Mr. Roland DeAngelis	Chief Marketing Officer
Mr. Dominick C. Colangelo Esq.	CEO, President & Director
Dr. Jonathan M. Hopper FRCSEd., M.B. Ch.B.	Chief Medical Officer
Mr. Patrick J. Fowler	Senior Vice President of Corporate Development & Strategy

FAQs

What is Vericel Corporation share price today?

Vericel Corporation share price today is $33.3 as on March 25, 2026 at 12:40 am IST. Vericel Corporation share today touched a day high of $33.5 and a low of $32.02.

What is the 52 week high and 52 week low for Vericel Corporation share?

Vericel Corporation share touched a 52 week high of $48.75 on March 25, 2025 and a 52 week low of $29.24 on September 25, 2025. Vericel Corporation stock price today i.e. March 25, 2026 at 12:40 am IST is trending at $33.3,which is 31.69% down from its 52 week high and 13.89% up from its 52 week low.

What is Vericel Corporation's market capitalisation today?

Vericel Corporation market capitalisation is $0.00T as on March 25, 2026 at 12:40 am IST.

How to invest in Vericel Corporation Stock (VCEL) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Vericel Corporation on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Vericel Corporation Shares that will get you 0.0450 shares as per Vericel Corporation share price of $33.3 per share as on March 25, 2026 at 12:40 am IST.

What is the minimum amount required to buy Vericel Corporation Stock (VCEL) from India?

Indian investors can start investing in Vericel Corporation (VCEL) shares with as little as ₹93.734 or $1 (as of March 25, 2026 at 12:40 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹937.34 in Vericel Corporation stock (as per the Rupee-Dollar exchange rate as on March 25, 2026 at 12:40 am IST). Based on Vericel Corporation share’s latest price of $33.3 as on March 25, 2026 at 12:40 am IST, you will get 0.3003 shares of Vericel Corporation. Learn more about fractional shares .

What are the returns that Vericel Corporation has given to Indian investors in the last 5 years?

Vericel Corporation stock has given -43.48% share price returns and 28.4% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?